Lisinopril vs Nivolumab
Lisinopril vs Nivolumab: Overview
This comparison examines the pharmacological differences between Lisinopril and Nivolumab.
Mechanism of Action
Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Lisinopril β 12 hours; Nivolumab β 27 days.
Chemical Properties
Molecular Formula: Lisinopril β C21H31N3O5.
Molecular Weight: Lisinopril β 405.4900 g/mol.
Type: Lisinopril β Small molecule; Nivolumab β Antibody.